- Home
- ALKS vs MSGS Comparison
ALKS vs MSGS Comparison
Compare ALKS & MSGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALKS
- MSGS
- Stock Information
- Founded
- ALKS 1987
- MSGS 1879
- Country
- ALKS Ireland
- MSGS United States
- Employees
- ALKS N/A
- MSGS N/A
- Industry
- ALKS Biotechnology: Pharmaceutical Preparations
- MSGS Services-Misc. Amusement & Recreation
- Sector
- ALKS Health Care
- MSGS Consumer Discretionary
- Exchange
- ALKS Nasdaq
- MSGS Nasdaq
- Market Cap
- ALKS 4.8B
- MSGS 5.2B
- IPO Year
- ALKS 1991
- MSGS N/A
- Fundamental
- Price
- ALKS $27.69
- MSGS $227.71
- Analyst Decision
- ALKS Buy
- MSGS Buy
- Analyst Count
- ALKS 12
- MSGS 1
- Target Price
- ALKS $35.42
- MSGS $240.00
- AVG Volume (30 Days)
- ALKS 1.9M
- MSGS 126.5K
- Earning Date
- ALKS 10-24-2024
- MSGS 11-01-2024
- Dividend Yield
- ALKS N/A
- MSGS N/A
- EPS Growth
- ALKS 55.25
- MSGS 57.82
- EPS
- ALKS 1.97
- MSGS 2.91
- Revenue
- ALKS $1,505,121,000.00
- MSGS $1,037,410,000.00
- Revenue This Year
- ALKS N/A
- MSGS N/A
- Revenue Next Year
- ALKS N/A
- MSGS $8.60
- P/E Ratio
- ALKS $14.17
- MSGS $76.25
- Revenue Growth
- ALKS N/A
- MSGS 14.45
- 52 Week Low
- ALKS $22.22
- MSGS $166.26
- 52 Week High
- ALKS $32.88
- MSGS $230.69
- Technical
- Relative Strength Index (RSI)
- ALKS 50.45
- MSGS 57.24
- Support Level
- ALKS $27.11
- MSGS $216.66
- Resistance Level
- ALKS $28.29
- MSGS $224.79
- Average True Range (ATR)
- ALKS 0.87
- MSGS 4.33
- MACD
- ALKS -0.07
- MSGS -0.43
- Stochastic Oscillator
- ALKS 45.42
- MSGS 63.12
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
About MSGS Madison Square Garden Sports Corp. (New)
Madison Square Garden Sports Corp owns and operates a portfolio of assets featuring some of the recognized sports teams, including the Knicks of the NBA and the Rangers of the NHL. It generates revenue from several sources: ticket sales and a portion of suite rental fees at The Garden and others. It has one operating and reportable segment and one reporting unit for goodwill impairment testing purposes.